182 related articles for article (PubMed ID: 35129780)
1. MALAT-1/p53/miR-155/miR-146a ceRNA circuit tuned by methoxylated quercitin glycoside alters immunogenic and oncogenic profiles of breast cancer.
Abdel-Latif M; Riad A; Soliman RA; Elkhouly AM; Nafae H; Gad MZ; Motaal AA; Youness RA
Mol Cell Biochem; 2022 Apr; 477(4):1281-1293. PubMed ID: 35129780
[TBL] [Abstract][Full Text] [Related]
2. The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a.
Youness RA; Hafez HM; Khallaf E; Assal RA; Abdel Motaal A; Gad MZ
J Cell Physiol; 2019 Nov; 234(11):20286-20297. PubMed ID: 30968427
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HEIH/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production.
Nafea H; Youness RA; Abou-Aisha K; Gad MZ
J Cell Physiol; 2021 Jul; 236(7):5362-5372. PubMed ID: 33368266
[TBL] [Abstract][Full Text] [Related]
4. MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer.
Mekky RY; Ragab MF; Manie T; Attia AA; Youness RA
Transl Oncol; 2023 May; 31():101653. PubMed ID: 36907052
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
Qiao Y; Wang B; Yan Y; Niu L
Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
[TBL] [Abstract][Full Text] [Related]
6. MALAT-1: LncRNA ruling miR-182/PIG-C/mesothelin triad in triple negative breast cancer.
Barsoum FS; Awad AS; Hussein NH; Eissa RA; El Tayebi HM
Pathol Res Pract; 2020 Dec; 216(12):153274. PubMed ID: 33171372
[TBL] [Abstract][Full Text] [Related]
7. A methoxylated quercetin glycoside harnesses HCC tumor progression in a TP53/miR-15/miR-16 dependent manner.
Ahmed Youness R; Amr Assal R; Mohamed Ezzat S; Zakaria Gad M; Abdel Motaal A
Nat Prod Res; 2020 May; 34(10):1475-1480. PubMed ID: 30526087
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
[TBL] [Abstract][Full Text] [Related]
9. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W
Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169
[TBL] [Abstract][Full Text] [Related]
10. A novel role of sONE/NOS3/NO signaling cascade in mediating hydrogen sulphide bilateral effects on triple negative breast cancer progression.
Youness RA; Assal RA; Abdel Motaal A; Gad MZ
Nitric Oxide; 2018 Nov; 80():12-23. PubMed ID: 30081213
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA profiling identifies Forkhead box transcription factor M1 (FOXM1) regulated miR-186 and miR-200b alterations in triple negative breast cancer.
Hamurcu Z; Sener EF; Taheri S; Nalbantoglu U; Kokcu ND; Tahtasakal R; Cınar V; Guler A; Ozkul Y; Dönmez-Altuntas H; Ozpolat B
Cell Signal; 2021 Jul; 83():109979. PubMed ID: 33744419
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
[TBL] [Abstract][Full Text] [Related]
13. Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer.
Shen J; Pan J; Du C; Si W; Yao M; Xu L; Zheng H; Xu M; Chen D; Wang S; Fu P; Fan W
Cell Death Dis; 2017 Apr; 8(4):e2740. PubMed ID: 28383557
[TBL] [Abstract][Full Text] [Related]
14. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
Han C; Li X; Fan Q; Liu G; Yin J
Aging (Albany NY); 2019 Jul; 11(14):4858-4875. PubMed ID: 31310241
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells.
Breunig C; Pahl J; Küblbeck M; Miller M; Antonelli D; Erdem N; Wirth C; Will R; Bott A; Cerwenka A; Wiemann S
Cell Death Dis; 2017 Aug; 8(8):e2973. PubMed ID: 28771222
[TBL] [Abstract][Full Text] [Related]
16. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer.
Wu J; Xu W; Ma L; Sheng J; Ye M; Chen H; Zhang Y; Wang B; Liao M; Meng T; Zhou Y; Chen H
Aging (Albany NY); 2021 Jul; 13(14):18191-18222. PubMed ID: 34289449
[TBL] [Abstract][Full Text] [Related]
17. lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6.
Eades G; Wolfson B; Zhang Y; Li Q; Yao Y; Zhou Q
Mol Cancer Res; 2015 Feb; 13(2):330-8. PubMed ID: 25253741
[TBL] [Abstract][Full Text] [Related]
18. lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression.
Zhang X; Zhou Y; Mao F; Lin Y; Shen S; Sun Q
Sci Rep; 2020 May; 10(1):7662. PubMed ID: 32376943
[TBL] [Abstract][Full Text] [Related]
19. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
Han C; Fu Y; Zeng N; Yin J; Li Q
Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
[TBL] [Abstract][Full Text] [Related]
20. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
